Affordability Check
How to afford Inrebic
Generic name: Fedratinib Hydrochloride
Pick how you're covered. We'll show you the cheapest legitimate way to get Inrebic — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Inrebic and its cost
What is this medication? Inrebic is a prescription medication used to treat adults with specific forms of myelofibrosis, which is a serious bone marrow disorder that disrupts the body's normal production of blood cells. This drug is indicated for patients diagnosed with intermediate-2 or high-risk primary myelofibrosis, as well as secondary myelofibrosis that occurs following polycythemia vera or essential thrombocythemia. By targeting the underlying mechanisms of these conditions, the medication helps manage the progression of the disease and its impact on the bone marrow.
The active ingredient in Inrebic is fedratinib, a type of kinase inhibitor that works by blocking certain enzymes, including Janus Associated Kinase 2. These enzymes are often overactive in people with myelofibrosis and contribute to the growth of abnormal cells and inflammation. By interfering with these signals, the medication can effectively reduce the size of an enlarged spleen and improve common symptoms such as bone pain, night sweats, itching, and fatigue.
Inrebic is made by a pharmaceutical manufacturer. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Inrebic?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Inrebic?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But the manufacturer has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Inrebic?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Essential Thrombocythemia?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Inrebic
Full Inrebic drug page
FDA label, prior authorization rules, full indications list
More options for Essential Thrombocythemia
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3